Transaction in Own Shares

Summary by AI BETAClose X

3i Group plc has purchased 1,111,525 ordinary shares for cancellation as part of its £750 million share buyback programme, with transactions occurring between July 13th and July 17th, 2026, at prices ranging from £25.82 to £27.24 per share. The volume-weighted average price paid across these transactions was £26.50. Following these purchases, the total number of voting rights in 3i is now 1,009,972,661. Since the programme began, 3i has repurchased 14,739,302 shares for a total cost of £342,275,929.11.

Disclaimer*

3i Group PLC
20 July 2026
 

20 July 2026

                               

3i GROUP PLC

 

TRANSACTIONS IN OWN SHARES

 

 

 

3i Group plc (the "Company" or "3i") announces today that it has purchased for cancellation the following number of its ordinary shares of 73 19/22p each ("Shares") through Barclays Capital Securities Limited as part of the £750 million share buyback programme announced by 3i on 14 May 2026 (the "Programme"):

 

Date of transactions

Trading Venues

Aggregated volume (Shares)

Lowest Price per Share (£)

Highest Price per Share (£)

Volume weighted average price paid per share (£)

13/07/2026

London Stock Exchange

222,305

26.5700

27.2400

26.8416

14/07/2026

London Stock Exchange

222,305

26.0000

26.8000

26.3794

15/07/2026

London Stock Exchange

222,305

26.2400

26.8100

26.6128

16/07/2026

London Stock Exchange

222,305

26.2200

26.6500

26.5152

17/07/2026

London Stock Exchange

222,305

25.8200

26.5700

26.1541

 

 

Following the above purchase and cancellation of the Shares, the total number of voting rights in 3i will be 1,009,972,661 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 3i does not hold any shares in treasury.

 

Since the commencement of this Programme, 3i has purchased 14,739,302 Shares for cancellation at an aggregate cost of £342,275,929.11 (excluding fees and taxes).

 

In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), a full breakdown of the individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the Programme is detailed below.

 


This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

http://www.rns-pdf.londonstockexchange.com/rns/9019M_1-2026-7-18.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

3i Group (III)
UK 100

Latest directors dealings